title: Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition.
abstract: Chronic obstructive pulmonary disease (COPD) and lung cancer are two diseases that are related to smoking in humans. The molecular mechanism linking these two diseases is poorly understood. Matrix metalloproteinase 12 (MMP12) is a member of the MMP family, which can be induced by smoking. Because MMP12 overexpression in epithelial cells has been reported in inflammation-triggered lung remodeling, a murine CCSP-rtTA/(tetO)(7)-MMP12 bitransgenic model was created. In this model, MMP12-Flag fusion protein overexpression and its increased enzymatic activity were observed in the lung in an inducible manner, which led to inflammatory cell infiltration and increased epithelial growth. In sequential events, spontaneous emphysema and bronchioalveolar adenocarcinoma were developed as a result of MMP12 overexpression. During this process, the concentration of interleukin-6 was steadily increased in bronchioalveolar lavage fluid, which activated the oncogenic signal transducer and activator of transcription 3 (Stat3) in alveolar type II epithelial cells. Expression of Stat3 downstream genes that are known to stimulate inflammation and tumor formation was significantly increased in the lung. When tested in humans, MMP12 up-regulation was highly associated with COPD and lung cancer in patients. Together, these studies support that MMP12 is a potent proinflammatory and oncogenic molecule. MMP12 up-regulation plays a critical role in emphysema to lung cancer transition that is facilitated by inflammation.
authors.affiliation: The Center for Immunobiology, Simon Cancer Center and Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202-5188, USA.
authors.forename: Peng
authors.initials: P
authors.lastname: Qu
authors.forename: Hong
authors.initials: H
authors.lastname: Du
authors.forename: Xi
authors.initials: X
authors.lastname: Wang
authors.forename: Cong
authors.initials: C
authors.lastname: Yan
mesh_terms: D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D000818:Animals; D017209:Apoptosis / Q000502:physiology; D002294:Carcinoma, Squamous Cell / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D048708:Cell Growth Processes / Q000502:physiology; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D053508:Matrix Metalloproteinase 12 / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D029424:Pulmonary Disease, Chronic Obstructive / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D011656:Pulmonary Emphysema / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D015854:Up-Regulation
chemical_list: D053508:Matrix Metalloproteinase 12
references.citation: J Exp Med. 1975 Aug 1;142(2):361-77
references.pmid: 167096
references.citation: Am J Respir Cell Mol Biol. 2000 Mar;22(3):289-95
references.pmid: 10696065
references.citation: Clin Cancer Res. 2006 Dec 1;12(23):7009-17
references.pmid: 17145822
references.citation: Lung Cancer. 2009 Mar;63(3):341-7
references.pmid: 18614255
references.citation: Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33
references.pmid: 17318226
references.citation: PPAR Res. 2008;2008:254108
references.pmid: 18704200
references.citation: Gene Ther. 2007 Oct;14(20):1461-70
references.pmid: 17700706
references.citation: Am J Physiol Lung Cell Mol Physiol. 2004 Apr;286(4):L801-7
references.pmid: 14644759
references.citation: Am J Pathol. 2005 Sep;167(3):813-21
references.pmid: 16127159
references.citation: FASEB J. 1999 May;13(8):781-92
references.pmid: 10224222
references.citation: Science. 1997 Sep 26;277(5334):2002-4
references.pmid: 9302297
references.citation: Immunity. 2004 Feb;20(2):205-18
references.pmid: 14975242
references.citation: Clin Cancer Res. 2005 Feb 1;11(3):1086-92
references.pmid: 15709175
references.citation: Am J Physiol. 1993 Dec;265(6 Pt 1):L521-48
references.pmid: 8279570
references.citation: Am J Pathol. 2009 Mar;174(3):944-56
references.pmid: 19179613
references.citation: J Clin Invest. 2007 May;117(5):1155-66
references.pmid: 17476345
references.citation: Cancer Res. 2007 Sep 15;67(18):8494-503
references.pmid: 17875688
references.citation: J Immunol. 2005 Jun 1;174(11):7250-6
references.pmid: 15905571
references.citation: Am J Pathol. 2006 Sep;169(3):916-26
references.pmid: 16936266
references.citation: J Biol Chem. 1993 Nov 15;268(32):23824-9
references.pmid: 8226919
references.citation: Nat Med. 1997 Jun;3(6):675-7
references.pmid: 9176496
references.citation: J Biol Chem. 1997 May 2;272(18):12189-94
references.pmid: 9115292
references.citation: J Immunol. 2009 Feb 1;182(3):1648-59
references.pmid: 19155514
references.citation: Nat Rev Immunol. 2004 Aug;4(8):617-29
references.pmid: 15286728
references.citation: Arch Intern Med. 2003 Jun 23;163(12):1475-80
references.pmid: 12824098
references.citation: Stem Cells. 1997;15(3):180-9
references.pmid: 9170209
references.citation: Blood. 2000 Dec 1;96(12):3838-46
references.pmid: 11090068
references.citation: Lung Cancer. 2007 May;56(2):175-84
references.pmid: 17258348
references.citation: Am J Respir Cell Mol Biol. 1999 Jun;20(6):1100-2
references.pmid: 10340927
references.citation: J Biol Chem. 2000 Apr 21;275(16):11858-64
references.pmid: 10766812